Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice.

Wang Z, Wang Y, Yang T, Li J, Yang X.

Stem Cell Res Ther. 2017 Jan 23;8(1):11. doi: 10.1186/s13287-016-0458-1. Erratum in: Stem Cell Res Ther. 2017 Mar 8;8(1):49.

2.

The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis.

Baratloo A, Safari S, Rouhipour A, Hashemi B, Rahmati F, Motamedi M, Forouzanfar M, Haroutunian P.

Emerg (Tehran). 2014 Winter;2(1):1-11. Review.

3.

Effects of Polygonatum sibiricum polysaccharide on the osteogenic differentiation of bone mesenchymal stem cells in mice.

Zong S, Zeng G, Zou B, Li K, Fang Y, Lu L, Xiao D, Zhang Z.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6169-80. eCollection 2015.

4.

Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.

Onitilo AA, Doi SA, Engel JM, Glurich I, Johnson J, Berg R.

Thromb Res. 2012 Jul;130(1):27-31. doi: 10.1016/j.thromres.2011.11.025. Epub 2011 Dec 7.

5.

The TU-025 keishibukuryogan clinical trial for hot flash management in postmenopausal women: results and lessons for future research.

Plotnikoff GA, Watanabe K, Torkelson C, La Valleur J, Radosevich DM.

Menopause. 2011 Aug;18(8):886-92. doi: 10.1097/gme.0b013e31821643d9.

6.

Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Masood DE, Roach EC, Beauregard KG, Khalil RA.

Curr Drug Metab. 2010 Oct;11(8):693-714. Review.

7.

Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Gibbs RB.

Endocr Rev. 2010 Apr;31(2):224-53. doi: 10.1210/er.2009-0036. Epub 2009 Dec 17. Review.

8.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY.

BMJ. 2008 May 31;336(7655):1227-31. doi: 10.1136/bmj.39555.441944.BE. Epub 2008 May 20. Review.

9.

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Rocha AT, Paiva EF, Lichtenstein A, Milani R Jr, Cavalheiro CF, Maffei FH.

Vasc Health Risk Manag. 2007;3(4):533-53. Review.

10.

Hormone replacement therapy after the menopause--where are we now?

Rymer J, Sturdee DW.

Br J Gen Pract. 2005 Mar;55(512):172-4. No abstract available. Erratum in: Br J Gen Pract. 2005 May;55(514):394.

11.

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.

Salpeter SR, Walsh JM, Greyber E, Ormiston TM, Salpeter EE.

J Gen Intern Med. 2004 Jul;19(7):791-804. Review.

12.

Benefits and harms associated with hormone replacement therapy: clinical decision analysis.

Minelli C, Abrams KR, Sutton AJ, Cooper NJ.

BMJ. 2004 Feb 14;328(7436):371.

13.

Risks and benefits of hormone replacement therapy: the evidence speaks.

Humphries KH, Gill S.

CMAJ. 2003 Apr 15;168(8):1001-10. Review.

Supplemental Content

Support Center